WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year ...
Sistani leaves the parent company of the once popular points-based weight loss program as it faces challenges in adapting to the growing popularity of weight loss drugs like Wegovy and Zepbound.
WeightWatchers announced Friday that CEO Sima Sistani has stepped down from the job and is no longer on the company's board after 2½ years leading the weight loss company. Sistani has been ...
A weight loss program spruiked by some of the world’s top celebrities has outraged members by announcing it is discontinuing in-person meetings in a bid to become a completely virtual platform.
The New York-based weight loss company didn't reveal the reasons behind the abrupt move, but it noted that Comonte would step into the role of CEO at a time when the company is “focused on ...
Soaring demand for weight-loss drugs such as Wegovy and Eli Lilly's (LLY.N), opens new tab Zepbound, shown to help patients lose as much as 20% of weight on average, has led to shortages that ...